Dr. Jordan E. Perlman, MD

Dr. Perlman practices at Sibley Memorial Hospital in Washington, District of Columbia, part of Johns Hopkins Health System.

Dr. Perlman's NPI, 1952798290, was assigned on April 24, 2015. Dr. Perlman graduated from University of Vermont College of Medicine in 2015. Dr. Perlman holds Maryland license D0088758.

Dr. Perlman's primary practice is Sibley Memorial Hospital, at 5255 Loughboro Rd NW, Washington, DC 20016 in The District County. The practice phone is (202) 537-4680.

Dr. Perlman's primary practice is Sibley Memorial Hospital in Washington, District of Columbia, part of Johns Hopkins Health System. Dr. Perlman is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. Perlman to 4 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Perlman practices, 6 sites in all. Vendor and product names are available with a free account.

Endocrinology, diabetes and metabolism is Dr. Perlman's primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Dr. Perlman is licensed in Maryland.

CMS data shows 743 Medicare services from Dr. Perlman across 6 procedure codes in 2024, for 268 Medicare patients. Medicare paid $38,627 for them.

CMS counts 268 Medicare patients who saw Dr. Perlman in 2024. The largest group is 65 to 74, with 131 patients. 75% of them have diabetes, and 75% have high blood pressure. 23% are also on Medicaid. Their average risk score is 2.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Perlman's median patient age at 55, with 65% women.

In 2024, Dr. Perlman wrote 1,530 Medicare Part D claims for 226 patients. 29% of them were for generic drugs. CMS names the drug for 1,280 of them, across 33 drugs with 11 or more claims each, at $982,103 in total drug cost. In 2023, CMS named 795 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Perlman for performance year 2024, reported as part of a group. Dr. Perlman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Perlman as offering telehealth.

Dmand AI links 8 papers to Dr. Perlman, published from 2013 to 2025. 2021 was the busiest year, with 3. The most frequent topics are Blood Glucose, Blood Glucose Self-Monitoring and Diabetes Mellitus, Type 1. Dr. Perlman has published most often in Diabetes Technol Ther. Dr. Perlman's most frequent co-authors are Irl B. Hirsch, Gary Louis Gallia, MD, PhD and Ferdinand K. Hui, MD.

CMS Open Payments shows 7 general payments to Dr. Perlman from 4 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 87% of the total. Beta Bionics, Inc. paid the most, $197.

Dr. Perlman graduated from University of Vermont College of Medicine in 2015.